Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression
Sei Morinaga(Kanazawa University), Robert M. Hoffman(University of California San Diego), Byung Mo Kang(Sunnybrook Health Science Centre), Katsuhiro Hayashi(Kanazawa University), Norio Yamamoto, Shinji Miwa(Kanazawa University), KOHEI MIZUTA(University of the Ryukyus), Michael Bouvet(University of California San Diego Medical Center), Takashi Higuchi(Kyoto University), Kentaro Igarashi(Kanazawa University), Hiroaki Kimura(Kanazawa University), Qinghong Han(AntiCancer (United States)), Satoru Demura(Kanazawa University), Hiroyuki Tsuchiya(Kanazawa University)
Cited by 1
Related Papers
Release of oxytocin during suckling and parturition in the rat
|Journal of Endocrinology|1985|247
Oncologic Procedures Amenable to Fluorescence-guided Surgery
|Annals of Surgery|2016|155